AI and Proteomics Accelerate VAV1 Molecular Glue Discovery

T2Covered by 1 source · first reported by Fierce Biotech / Fierce Healthcare / MedCity / GEN at 30 Sept, 02:06 UTC

High-throughput proteomics combined with AI-based structural modeling helped researchers discover molecular glues that degrade VAV1. The approach could support new therapies for blood cancers and autoimmune diseases. The post AI and Proteomics Accelerate VAV1 Molecular Glue Discovery appeared first…

science

Sources

• T2AI and Proteomics Accelerate VAV1 Molecular Glue DiscoveryFierce Biotech / Fierce Healthcare / MedCity / GEN30 Sept, 02:06